|
|
|
|
|
|
|
|
|
08.12.25 - 18:06
|
Vertex Pharmaceuticals Aktie: Bullishes Update nach Labortour und Analystenmeeting (Aktiencheck)
|
|
|
New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Morgan Stanley:
Die Analysten von Morgan Stanley stufen die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807, Ticker-Symbol: VX1, NASDAQ-Symbol: VRTX) weiterhin mit "overweight" ein.
Morgan Stanley habe eine Labortour und ein Analystentreffen mit dem CEO sowie den Leitern des Nierenprogramms von Vertex Pharmaceuticals veranstaltet. [mehr]...
|
|
|
|
|
|
|
|
|
08.12.25 - 15:24
|
Futures Rise For 10th Day In Past 11 With Fed Rate Cut Looming (ZeroHedge)
|
|
|
Futures Rise For 10th Day In Past 11 With Fed Rate Cut Looming
With just 17 trading sessions left in 2025, stock futures edge higher again and are on pace for 10 gains in the past 11 days. S&P 500 futures were up 0.2% as of 5:32 a.m. in New York, with Nasdaq 100 contracts +0.3%. Pre-market, Mag 7 are mostly unchanged except for a -1.3% decline in TSLA on a downgrade from Morgan Stanley. Most Asian markets clock firm start to the week, while European markets are mixed. Bond yields are 1-2bp higher and the USD is flat after reversing an earlier drop. Commodities are mixed: oil and most base metals are down small, while precious metals are higher. Over the weekend, there were several corporate headlines: (i) MSFT is considering shift custom chip business to Broadcom from Marvell (The Information). (ii) Trump warned the Netflix-Warner deal may post antitrust problem (BBG); (iii) IBM close to buy Confluent. A Fed cut on Wednesday looks like a done deal, but the trajectory after that is less clear....
|
|
|
|
|
|
|
|
|
08.12.25 - 12:48
|
ECB′s Schnabel ′Comfortable′ With Rate Hike Bets, China to Boost Domestic Demand | The Pulse 12/8 (Bloomberg)
|
|
|
"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops.
Today's guests: Anne Walsh, Guggenheim Investments CIO; Deepak Nath, Smith & Nephew CEO; James Lord, Morgan Stanley, Global Head of FX & EM Strategy; Natia Seskuria, RUSI Associate Fellow (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
08.12.25 - 08:12
|
Tesla: Dauer-Optimist Morgan Stanley stuft ab – Aktie kein Kauf mehr (Der Aktionaer)
|
|
|
Morgan Stanley vollzieht eine bemerkenswerte Kehrtwende: Der neue zuständige Analyst Andrew Percoco nimmt Tesla von der Kaufliste und stuft die Aktie auf „Equal Weight“ ab. Zwar erhöht er das Kursziel leicht auf 425 Dollar, signalisiert damit aber immer noch ein moderates Abwärtspotenzial gegenüber dem jüngsten Kursniveau....
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
